Skip to content

Bausch + Lomb Corp.

US · BLCO #1909 by market cap Listed 2022
19.38 -1.31 -6.33%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Bausch + Lomb Corp.

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Founded
2020
CEO
Mr. Thomas J. Appio
Employees
13,000
Headquarters
Vaughan, Ontario, Canada
Fiscal year end
12-31
Website
bausch.com

Company profile

Exchange
US
Symbol
BLCO
Market-cap rank
#1909
Listing date
2022-05-06
Market cap
6.93B
Float cap
898.97M
Shares out
357.50M
Float shares
46.39M

Sectors & themes

Medical Instruments & Supplies Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Bausch + Lomb Corp. discussion 0 comments

Add a comment